Crossmark

Tamoxifen administration and risk of Parkinson’s disease

Crossref DOI link: https://doi.org/10.1007/s00228-018-2553-y

Published Online: 2018-09-10

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Shih-Wei https://orcid.org/0000-0002-7420-1572
License Information

Text and Data Mining valid from 2018-09-10
More Information

Article History

Received: 17 August 2018

Accepted: 30 August 2018

First Online: 10 September 2018

Compliance with ethical standards

:

: The author declares that there are no competing interests.